PRO in Pts With Rare Cancers: Pembrolizumab [2022] Immunotherapy 11 Mins Read3 PRO in Pts With Rare Cancers: Pembrolizumab [2022] Â Patient reported Outcome (PRO) in patients with rare cancers (rare diseases)…
